CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Ocular Therapeutix - CapyFin

Ocular Therapeutix

OCUL · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $14.8M

Previous year: -$0.28

Previous year: $20.7M

Sales & Marketing Exp

Previous year: $10.2M

Previous year: $14.1M

Previous year: $13.4M

Cash and Equivalents

Previous year: $483M

Previous year: -$34.1M

Previous year: $539M

Loading...

Key Statistics

Market Cap

$1.95B

P/E Ratio

-7.93

Sector

N/A

Industry

N/A

52-Week High

$16.1

52-Week Low

$5.91

R&D Expense

$42.9M

Sales & Marketing Exp

$14.1M

G&A Expense

$16.3M

Outstanding Shares

159.26M

Ocular Therapeutix

Unlock previous datapoints

Ocular Therapeutix

Unlock previous datapoints

Ocular Therapeutix Revenue by Segment

Revenue by Segment

Product Revenue

Unlock previous datapoints

CapyFin.com

Collaboration Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...